Biotalys logo — Pioneering Precision Biocontrols

Biotalys

Pioneering Precision Biocontrols

Founded 2013 Belgium Belgium 48 employees Post Ipo Equity Total: $70.30M Agriculture, Biotechnology +1

General Information

Company Name Biotalys
Founded Year 2013
Location Belgium Belgium +1
Employees 48
Industries Agriculture, Biotechnology, AgriTech
Funding Stage Post Ipo Equity
Social

Get notified when Biotalys moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 08, 2026

Biotalys's CEO Carlo Boutton will be a speaker at a session on bringing innovations to market, taking place in Wintercircus Ghent on October 27, 2026.

Regulatory Approval Sep 02, 2026

Biotalys announced the grant of state registration for its EVOCA® protein-based biofungicide by the California Department of Pesticide Regulation (CDPR).

Award Received Aug 27, 2026

Biotalys was recognized by GPN-Greenhouse Product News as one of the key innovators in biological crop protection solutions, as highlighted in an article by the trade magazine.

Key Hire Aug 20, 2026

Biotalys announced the appointment of Carlo Boutton as its new Chief Executive Officer, confirming his leadership after serving as CEO ad interim since March 2026.

About Biotalys

Biotalys, founded in 2013, is a prominent player in the Agriculture, Biotechnology, and AgriTech industries, known for its pioneering work in precision biocontrols. With headquarters in Belgium, specifically within the biotech cluster in Ghent, the company utilizes its innovative AGROBODY™ technology platform to develop biocontrol solutions that combine the effectiveness of chemicals with the sustainability of biological methods.

Biotalys addresses key agricultural challenges by offering a diverse pipeline of protein-based solutions that enhance crop protection from soil to plate. The company, a spin-off from the VIB (Flanders Institute for Biotechnology), is publicly traded on Euronext Brussels.

Their most recent financing activity involved a Post-IPO Equity investment on 14 October 2024, though investor details were not disclosed. Biotalys' focus on environmental sustainability and agricultural innovation positions it as a compelling target for investors seeking impactful opportunities in the agri-biotechnology space.

Taxonomy: Precision Biocontrols, Agrobody Technology, Protein-based Solutions, Crop Protection, Pre-harvest Applications, Post-harvest Applications, Biocontrol Solutions, Agricultural Technology, Biotech Innovation, Sustainable Agriculture, VIB Spin-off, Food Safety, Environmental Impact

Services & Products

Development of protein-based biocontrol solutions
Crop protection innovation
Extension of post-harvest protection

Target Customers

Farmers Agricultural industry stakeholders Shareholders and investors

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 14 Oct 2024
Grant •••••• 1
Investor
20 Oct 2021
Series C •••••• - 01 Oct 2021
Grant •••••• 1 •••• •••• 01 Oct 2020
Grant •••••• 1 •••• •••• 26 May 2020

View All 9 Funding Rounds

Biotalys Alternatives & Competitors

View All Alternatives
Biotalys vs

Revolutionizing Hormone Diagnostics

Biotalys vs
SWIR Vision Systems
SWIR Vision Systems United States

Transforming Infrared Imaging

Series A
8 employees
Manufacturing, Mobile
Biotalys vs
Ai2 Ltd
Ai2 Ltd United Kingdom

Ai2 Ltd is a UK-based biotechnology company that specialises in novel anti-infective peptide technol...

Series Unknown
3 employees
Biopharma, Biotechnology

FAQ About Biotalys

Pioneering Precision Biocontrols
Biotalys was founded in 2013.
Biotalys is headquartered in Belgium.
Biotalys operates in the following industries: Agriculture, Biotechnology, AgriTech.
Biotalys has approximately 48 employees.
Biotalys has completed 9 funding rounds, raising a total of $70.30M. The latest funding stage is Post Ipo Equity.
Biotalys offers: Development of protein-based biocontrol solutions, Crop protection innovation, Extension of post-harvest protection.
Top alternatives and competitors to Biotalys include ICDx, SWIR Vision Systems, Ai2 Ltd, Web Minds IT Solution, Cerevast Medical, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biotalys and ICDx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Biotalys and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy